Health Boards
Tue-08-10-2019, 12:37 PM
Update to this thread:
NHS Scotland have approved restricted use of Skyrizi for patients who have failed to respond to conventional systemic therapies (including ciclosporin, methotrexate and phototherapy), are intolerant to, or have a contraindication to these treatments.
NHS Scotland have approved restricted use of Skyrizi for patients who have failed to respond to conventional systemic therapies (including ciclosporin, methotrexate and phototherapy), are intolerant to, or have a contraindication to these treatments.
